Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mikael Feracci

Showing results (1-10 of 16) with videos related to

Pageof 2
Sort By:
Methods (San Diego, Calif.)|October 8, 2013
Screening protein--single stranded RNA complexes by NMR spectroscopy for structure determinationJaelle N Foot, Mikael Feracci, Cyril Dominguez
Biochemical Society Transactions|August 12, 2014
Structural investigations of the RNA-binding properties of STAR proteinsMikael Feracci, Jaelle Foot, Cyril Dominguez
Biophysical Journal|December 17, 2009
NMR and MD investigations of human galectin-1/oligosaccharide complexesChristophe Meynier, Mikael Feracci, Marion Espeli, et al.
Iucrj|April 24, 2024
Biophysical and structural study of La Crosse virus endonuclease inhibition for the development of new antiviral optionsMikael Feracci, Sergio Hernandez, Laura Garlatti, et al.
Plos Biology|August 27, 2024
The activation cascade of the broad-spectrum antiviral bemnifosbuvir characterized at atomic resolutionAurélie Chazot, Claire Zimberger, Mikael Feracci, et al.
The Journal of Biological Chemistry|November 6, 2012
Structural basis for galectin-1-dependent pre-B cell receptor (pre-BCR) activationLatifa Elantak, Marion Espeli, Annie Boned, et al.
European Journal of Medicinal Chemistry|June 21, 2021
Fragment-based drug design targeting syntenin PDZ2 domain involved in exosomal release and tumour spreadManon Garcia, Laurent Hoffer, Raphaël Leblanc, et al.
Nucleic Acids Research|December 14, 2023
An exonuclease-resistant chain-terminating nucleotide analogue targeting the SARS-CoV-2 replicase complexAshleigh Shannon, Aurélie Chazot, Mikael Feracci, et al.
Journal of Medicinal Chemistry|March 20, 2023
Discovery of a PDZ Domain Inhibitor Targeting the Syndecan/Syntenin Protein-Protein Interaction: A Semi-Automated "Hit Identification-to-Optimization" ApproachLaurent Hoffer, Manon Garcia, Raphael Leblanc, et al.
Molecular Oncology|October 6, 2020
In silico molecular target prediction unveils mebendazole as a potent MAPK14 inhibitorJeremy Ariey-Bonnet, Kendall Carrasco, Marion Le Grand, et al.
Pageof 2

Showing results (1-10 of 16) with videos related to

Sort By:
Pageof 2
Methods (San Diego, Calif.)|October 8, 2013
Screening protein--single stranded RNA complexes by NMR spectroscopy for structure determinationJaelle N Foot, Mikael Feracci, Cyril Dominguez
Biochemical Society Transactions|August 12, 2014
Structural investigations of the RNA-binding properties of STAR proteinsMikael Feracci, Jaelle Foot, Cyril Dominguez
Biophysical Journal|December 17, 2009
NMR and MD investigations of human galectin-1/oligosaccharide complexesChristophe Meynier, Mikael Feracci, Marion Espeli, et al.
Iucrj|April 24, 2024
Biophysical and structural study of La Crosse virus endonuclease inhibition for the development of new antiviral optionsMikael Feracci, Sergio Hernandez, Laura Garlatti, et al.
Plos Biology|August 27, 2024
The activation cascade of the broad-spectrum antiviral bemnifosbuvir characterized at atomic resolutionAurélie Chazot, Claire Zimberger, Mikael Feracci, et al.
The Journal of Biological Chemistry|November 6, 2012
Structural basis for galectin-1-dependent pre-B cell receptor (pre-BCR) activationLatifa Elantak, Marion Espeli, Annie Boned, et al.
European Journal of Medicinal Chemistry|June 21, 2021
Fragment-based drug design targeting syntenin PDZ2 domain involved in exosomal release and tumour spreadManon Garcia, Laurent Hoffer, Raphaël Leblanc, et al.
Nucleic Acids Research|December 14, 2023
An exonuclease-resistant chain-terminating nucleotide analogue targeting the SARS-CoV-2 replicase complexAshleigh Shannon, Aurélie Chazot, Mikael Feracci, et al.
Journal of Medicinal Chemistry|March 20, 2023
Discovery of a PDZ Domain Inhibitor Targeting the Syndecan/Syntenin Protein-Protein Interaction: A Semi-Automated "Hit Identification-to-Optimization" ApproachLaurent Hoffer, Manon Garcia, Raphael Leblanc, et al.
Molecular Oncology|October 6, 2020
In silico molecular target prediction unveils mebendazole as a potent MAPK14 inhibitorJeremy Ariey-Bonnet, Kendall Carrasco, Marion Le Grand, et al.
Pageof 2